The first multisite study of psychedelics outside of a clinical trial suggests psilocybin services in Oregon relieve symptoms of anxiety, depression and PTSD. Todd Korthuis, M.D., says, “Safety was very similar to what we’ve seen with psychedelics in clinical settings. That’s important because there was a big question around whether or not safety in carefully controlled psilocybin clinical trial would translate into real-world use.”

The first multisite study of psychedelics outside of a clinical trial suggests psilocybin services in Oregon relieve symptoms of anxiety, depression and PTSD. Todd Korthuis, M.D., says, “Safety was very similar to what we’ve seen with psychedelics in clinical settings. That’s important because there was a big question around whether or not safety in carefully controlled psilocybin clinical trial would translate into real-world use.”

Investopedia examines Washington’s WA Cares program, the nation’s first public long-term care insurance system and its potential as a model for other states. Hyunjee Kim, Ph.D., says the program could reveal both benefits and challenges for beneficiaries and caregivers. “A lot of people are watching how WA Cares unfolds,” she says.

A HuffPost article on what geriatric medicine experts wish people would do more often, Elizabeth Eckstrom, M.D., says: “It really is a lifetime of health that makes you have healthy aging and good longevity and good health span.” That said, she added, “ … no matter what age you are, you can start now and still have huge benefits from doing things — don’t let anyone think it’s too late to start with lifestyle changes.”

Tarvez Tucker, M.D., describes her experience in diagnosing death in the intensive care unit, or ICU, in an article published by Psychology Today; Tucker says: “The longest 10 minutes of my life are those I spend in perfect stillness and silence in the final throes of the brain death examination.” Tarvez’s book on this topic, “The Brain at Twilight: The Neuroscience of Our Last Words and Moments,” will publish in December 2026.

A first-of-its-kind global study led by OHSU revealed that the causes of traumatic brain injury worldwide vary greatly from country to country across the human development index. Ahmed Raslan, M.D., says, “You can’t solve a global brain injury crisis in operating rooms alone. This study shows the importance of fixing the systems that surround us."

A first-of-its-kind global study led by OHSU revealed that the causes of traumatic brain injury worldwide vary greatly from country to country across the human development index. Ahmed Raslan, M.D., says, “You can’t solve a global brain injury crisis in operating rooms alone. This study shows the importance of fixing the systems that surround us."

A first-of-its-kind global study led by OHSU revealed that the causes of traumatic brain injury worldwide vary greatly from country to country across the human development index. Ahmed Raslan, M.D., says, “You can’t solve a global brain injury crisis in operating rooms alone. This study shows the importance of fixing the systems that surround us."

Consumer Reports finds that nutrient levels in prenatal vitamins may differ from amounts stated on the labels. Danielle Prentice, D.O., says, “Adequate folic acid intake before conception and in early pregnancy is important for reducing the risk of neural tube defects. … folic acid is one of the clearest examples of why label accuracy matters.”

The first multisite study of psychedelics outside of a clinical trial suggests psilocybin services in Oregon relieve symptoms of anxiety, depression and PTSD. Todd Korthuis, M.D., says, “Safety was very similar to what we’ve seen with psychedelics in clinical settings. That’s important because there was a big question around whether or not safety in carefully controlled psilocybin clinical trial would translate into real-world use.”